Moderna Cuts Costs As Covid Vaccine Sales Decline; Shares Rise

Published 2 days ago Positive
Moderna Cuts Costs As Covid Vaccine Sales Decline; Shares Rise
Auto
Moderna stock surged Thursday after the Covid vaccine-maker significantly cut its third-quarter costs, and still managed to easily beat sales expectations.

Continue Reading

View Comments

More News

Qualcomm earned $215 target from BofA: Here’s what could derail it

1 hour ago Positive

Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

1 hour ago Positive

Why Iren Limited Rallied Again in October

1 hour ago Positive

What IREN (IREN)'s Landmark Microsoft AI Cloud Deal Means For Shareholders

1 hour ago Positive

FLR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLR

1 hour ago Positive